Avian and Rabbit Medicine Department, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.
Colleague, Avian and Rabbit Medicine Department, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.
BMC Vet Res. 2024 Sep 11;20(1):407. doi: 10.1186/s12917-024-04239-w.
Rabbit hemorrhagic disease (RHD) is an acute infectious disease that damages the rabbit industry by producing significant mortality rates in young and adult rabbits. RHD is better controlled by vaccination.
The current study's goal was to prepare and evaluate the immuno-enhancing effect of montanide ISA70 and aluminum hydroxide (Al(OH)) gel incorporated within the inactivated RHDV2 vaccine and assess the vaccine's protective efficacy against the homologous and heterologous local RHDV2 strains in rabbits.
Inactivated RHDV vaccines were prepared using Montanide ISA70 oil or Al(OH) gel adjuvants and submitted to sterility, safety, and potency tests. 200 rabbits were equally divided into 4 groups: G1 (control), G2 (vaccinated with gel-incorporated vaccine), G3 (vaccinated with montanide-incorporated vaccine), and G4 (vaccinated with gel- and montanide-incorporated vaccines). Individual blood samples were collected from one week to six months from all groups. The vaccine's potency was measured by the HI test and protection percentage post challenge.
Data revealed slightly increasing HI titer means reaching the 1st peak at 4 weeks post-vaccination (7.33, 7.67, and 7.33 log2 in the 2nd, 3rd, and 4th groups, respectively), then slightly decreasing and peaked again, giving 9.33 log2 for the2 group at 3 months post-vaccination (MPV), 10.67 log2 for 3rd the group, and 10.33 log2 for the 4th group at 5 months post-vaccination. Titer gradually decreased but remained protective. The protection rate ranged from 80-100% and 80-90% for homologous and heterologous local RHDV2 vaccines, respectively, within 3 weeks and 6 months post-challenge. The montanide oil RHDV2 vaccine induced better protection than the aluminum gel RHDV2 vaccine.
The results demonstrated evidence of cross-protection between RHDV2 strains. The oil emulsion vaccine induced higher and longer-lasting antibody titers than those obtained with the RHDV2 aluminum gel vaccine.
兔出血症(RHD)是一种急性传染病,可导致幼兔和成年兔死亡率显著升高,从而损害养兔业。通过接种疫苗可以更好地控制 RHD。
本研究旨在制备和评估 RHDV2 灭活疫苗中添加 montanide ISA70 和氢氧化铝(Al(OH))凝胶的免疫增强效果,并评估疫苗对同源和异源本地 RHDV2 株在兔子中的保护效力。
使用 Montanide ISA70 油或 Al(OH)凝胶佐剂制备 RHDV 灭活疫苗,并进行无菌性、安全性和效力测试。将 200 只兔子等分为 4 组:G1(对照组)、G2(接种凝胶疫苗)、G3(接种 montanide 疫苗)和 G4(接种凝胶和 montanide 疫苗)。从各组中收集 1 周至 6 个月的个体血液样本。通过 HI 试验和攻毒后保护率来测量疫苗效力。
数据显示,HI 滴度略有升高,在接种后第 4 周达到第 1 个峰值(第 2、3 和 4 组分别为 7.33、7.67 和 7.33 log2),然后略有下降并再次达到峰值,第 2 组在接种后 3 个月达到 9.33 log2(MPV),第 3 组为 10.67 log2,第 4 组为 5 个月时的 10.33 log2。滴度逐渐下降,但仍具有保护作用。同源和异源本地 RHDV2 疫苗的保护率分别在攻毒后 3 周和 6 个月内为 80-100%和 80-90%。montanide 油 RHDV2 疫苗诱导的保护效果优于铝凝胶 RHDV2 疫苗。
结果表明 RHDV2 株之间存在交叉保护作用。油乳剂疫苗诱导的抗体滴度高于 RHDV2 铝凝胶疫苗。